Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 8/2006

01-06-2006 | Letter to the editor

Third-degree heart block developing in a female patient with HLA-B27 positive ankylosing spondylitis

Authors: Vasfi Ulusoy, Aşkın Ateş, Hülya Çiçekcioğlu, Yonca Avcıoğlu, Yaşar Karaaslan

Published in: Rheumatology International | Issue 8/2006

Login to get access

Excerpt

Dear Sir, …
Literature
1.
Khan MA (2003) Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Mosby, London, pp 1161–1182
2.
Bergfeldt L (1997) HLA-B27–associated cardiac disease. Ann Intern Med 127:621–629PubMed
3.
Isohisa I, Tanaka M, Ishida H (1990) Sex influence on the cardiac complication of ankylosing spondylitis-analysis of 95 cases of ankylosing spondylitis including our case. Kokyu To Junkan 38:53–58PubMed
4.
Sukenik S, Pras A, Buskila D, Katz A, Snir Y, Horowitz J (1987) Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol 6:588–592PubMedCrossRef
5.
Bergfeldt L, Valin H, Edhag O (1984) Complete heart block in HLA-B27 associated disease. Electrophysiological and clinical characteristics. Br Heart J 51:184–188PubMedCrossRef
6.
Peeters AJ, ten Wolde S, Sedney MI, de Vries RR, Dijkmans BA (1991) Heart conduction disturbance: an HLA-B27 associated disease. Ann Rheum Dis 50:348–350PubMedCrossRef
Metadata
Title
Third-degree heart block developing in a female patient with HLA-B27 positive ankylosing spondylitis
Authors
Vasfi Ulusoy
Aşkın Ateş
Hülya Çiçekcioğlu
Yonca Avcıoğlu
Yaşar Karaaslan
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0067-2

Other articles of this Issue 8/2006

Rheumatology International 8/2006 Go to the issue

Original article

The presence of anti-mitochondrial antibodies in Chinese patients with liver involvement in systemic lupus erythematosus

Case Report

Regular abdominal pain and fever in each menstruation onset: an unusual menses-associated familial Mediterrenean fever attacks and a favor result on colchicine treatment

Original Article

Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus

Original Article

Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India

Case Report

Gottron’s papules-like eruption developing under hydroxyurea therapy

Case Report

SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits